Ionis Pharmaceuticals is gaining momentum as a top long-term growth stock in the biotech industry. With a strong pipeline of drugs in development, Ionis is poised for success in the future. Investors are taking notice of the company’s potential for significant growth and are keeping a close eye on its progress. This could be a promising opportunity for those looking to invest in the biotech sector. Keep an eye on Ionis as it continues to make strides in the pharmaceutical world.

Read more at Barchart: Why Morgan Stanley Upgraded This Biotech Stock to a Buy